🎁 Black Friday: up to 50% off of annual plans
IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.8006
-0.1965 (-19.71%)
At close: Nov 20, 2026, 4:00 PM EST
0.8505
+0.0499 (6.23%)
After-hours: Nov 20, 2026, 7:58 PM EST

IceCure Medical Statistics

Total Valuation

IceCure Medical has a market cap or net worth of $4.45 million. The enterprise value is -$3.06 million.

Market Cap4.45M
Enterprise Value -3.06M

Important Dates

The last earnings date was Wednesday, November 18, 2026, before market open.

Earnings Date Nov 18, 2026
Ex-Dividend Date n/a

Share Statistics

IceCure Medical has 5.56 million shares outstanding. The number of shares has increased by 68.28% in one year.

Current Share Class 5.56M
Shares Outstanding 5.56M
Shares Change (YoY) +68.28%
Shares Change (QoQ) +74.06%
Owned by Insiders (%) 22.02%
Owned by Institutions (%) 6.90%
Float 4.34M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.14
Forward PS 0.81
PB Ratio 0.51
P/TBV Ratio 0.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.08.

Current Ratio 2.51
Quick Ratio 1.73
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -506.09

Financial Efficiency

Return on equity (ROE) is -190.72% and return on invested capital (ROIC) is -112.76%.

Return on Equity (ROE) -190.72%
Return on Assets (ROA) -117.74%
Return on Invested Capital (ROIC) -112.76%
Return on Capital Employed (ROCE) -186.51%
Weighted Average Cost of Capital (WACC) 6.62%
Revenue Per Employee $56,826
Profits Per Employee -$249,870
Employee Count69
Asset Turnover 0.27
Inventory Turnover 0.97

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -96.19% in the last 52 weeks. The beta is 0.51, so IceCure Medical's price volatility has been lower than the market average.

Beta (5Y) 0.51
52-Week Price Change -96.19%
50-Day Moving Average 1.22
200-Day Moving Average 6.57
Relative Strength Index (RSI) 40.90
Average Volume (20 Days) 261,489

Short Selling Information

The latest short interest is 56,133, so 1.01% of the outstanding shares have been sold short.

Short Interest 56,133
Short Previous Month 42,182
Short % of Shares Out 1.01%
Short % of Float 1.29%
Short Ratio (days to cover) 0.33

Income Statement

In the last 12 months, IceCure Medical had revenue of $3.92 million and -$17.24 million in losses. Loss per share was -$5.17.

Revenue3.92M
Gross Profit 1.36M
Operating Income -17.21M
Pretax Income -17.24M
Net Income -17.24M
EBITDA -16.93M
EBIT -17.21M
Loss Per Share -$5.17
Full Income Statement

Balance Sheet

The company has $8.22 million in cash and $707,000 in debt, with a net cash position of $7.51 million or $1.35 per share.

Cash & Cash Equivalents 8.22M
Total Debt 707,000
Net Cash 7.51M
Net Cash Per Share $1.35
Equity (Book Value) 8.77M
Book Value Per Share 1.58
Working Capital 7.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.59 million and capital expenditures -$159,000, giving a free cash flow of -$17.75 million.

Operating Cash Flow -17.59M
Capital Expenditures -159,000
Depreciation & Amortization 278,000
Net Borrowing n/a
Free Cash Flow -17.75M
FCF Per Share -$3.19
Full Cash Flow Statement

Margins

Gross Margin 34.74%
Operating Margin -438.84%
Pretax Margin -439.71%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IceCure Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -68.28%
Shareholder Yield -68.28%
Earnings Yield -646.05%
FCF Yield -398.59%

Analyst Forecast

The average price target for IceCure Medical is $20.33, which is 2,439.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.33
Price Target Difference 2,439.35%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (3Y) 87.32%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on June 4, 2026. It was a reverse split with a ratio of 1:30.

Last Split Date Jun 4, 2026
Split Type Reverse
Split Ratio 1:30

Scores

IceCure Medical has an Altman Z-Score of -12.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -12.76
Piotroski F-Score 2